Neumora Therapeutics, Inc. (NMRA) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.45 | +5.2% |
| 2024 | $-1.53 | +57.9% |
| 2023 | $-3.63 | +24.5% |
| 2022 | $-4.81 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.45 | +5.2% |
| 2024 | $-1.53 | +57.9% |
| 2023 | $-3.63 | +24.5% |
| 2022 | $-4.81 | — |